There are 2789 resources available
384O - Laparoscopic versus open hemihepatectomy: The ORANGE II PLUS multicenter randomized controlled trial
Presenter: Robert Fichtinger
Session: Proffered Paper session - Gastrointestinal tumours, colorectal 2
Resources:
Abstract
Slides
Webcast
LBA22 - Neoadjuvant chemotherapy with oxaliplatin and capecitabine versus chemoradiation with capecitabine for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Initial results of a multicenter randomised, open-label, phase III trial
Presenter: Pei-Rong Ding
Session: Proffered Paper session - Gastrointestinal tumours, colorectal 2
Resources:
Abstract
Slides
Webcast
385O - Automated detection of microsatellite status in early colon cancer (CC) using artificial intelligence (AI) integrated infrared (IR) imaging on unstained samples from the AIO ColoPredictPlus 2.0 (CPP) registry study
Presenter: Frederik Großerüschkamp
Session: Proffered Paper session - Gastrointestinal tumours, colorectal 2
Resources:
Abstract
Slides
Webcast
833O - A phase Ib study result of HMPL-689, a PI3Kδ inhibitor, in Chinese patients with relapsed/refractory lymphoma
Presenter: Junning Cao
Session: Proffered Paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
LBA47 - Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of phase III Atalante-1 randomised trial
Presenter: Benjamin Besse
Session: Proffered Paper session - NSCLC, metastatic 2
Resources:
Abstract
Slides
Webcast
LBA35 - Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial
Presenter: Jean Bourhis
Session: Proffered Paper session - Head and neck cancer, excl. thyroid
Resources:
Abstract
Slides
Webcast
LBA36 - Nivolumab (N) + ipilimumab (I) vs EXTREME as first-line (1L) treatment (tx) for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Final results of CheckMate 651
Presenter: Athanassios Argiris
Session: Proffered Paper session - Head and neck cancer, excl. thyroid
Resources:
Abstract
Slides
Webcast
858O - Results of KEYNOTE-122: A phase III study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)
Presenter: Anthony T.C. Chan
Session: Proffered Paper session - Head and neck cancer, excl. thyroid
Resources:
Abstract
Slides
Webcast
859O - Refining TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma: A multicenter cohort study
Presenter: Wang-Zhong Li
Session: Proffered Paper session - Head and neck cancer, excl. thyroid
Resources:
Abstract
Slides
Webcast
LBA21 - Radioembolization with chemotherapy for colorectal liver metastases: A randomized, open-label, international, multicenter, phase III trial (EPOCH study)
Presenter: Mary Mulcahy
Session: Proffered Paper session - Gastrointestinal tumours, colorectal 2
Resources:
Abstract
Slides
Webcast